At a glance
ClinicalIndex Comparison RecordN/ACompleted· 235 enrolled
Drug / intervention
Angio-Seal VIP 6 French (6F) and 8 French (8F) devicesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platform (VIP) Vascular Closure Device
In Brief
An observational study evaluating Angio-Seal VIP 6 French (6F) and 8 French (8F) devices for Vascular Closure. Completed, enrolled 235 participants across 6 sites in 2 countries.
Detailed Summary
To characterize the clinical outcomes of Angio-Seal VIP with St. Jude Medical (SJM) collagen through the collection of device/procedure-related major vascular complications and time to hemostasis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Closure
CountriesGermany, Netherlands
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
First PostedMay 2013
Primary CompletionOct 2013
TodayJul 2026
First PostedMay 21, 2013
Enrollment StartMay 1, 2013
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.1 years ago
Interventions
Angio-Seal VIP 6 French (6F) and 8 French (8F) devicesdevice
These devices are used for the vascular closure procedure